{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:03:02Z","timestamp":1784264582606,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ajt.2024.09.018","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T21:49:33Z","timestamp":1727300973000},"page":"302-315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["FCGR2C Q13 and FCGR3A V176 alleles jointly associate with worse natural killer cell-mediated antibody-dependent cellular cytotoxicity and microvascular inflammation in kidney allograft antibody-mediated rejection"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6740-3961","authenticated-orcid":false,"given":"Elodie","family":"Bailly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3624-1896","authenticated-orcid":false,"given":"Camila","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6854-5048","authenticated-orcid":false,"given":"Xinyan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8906-3475","authenticated-orcid":false,"given":"Deborah","family":"Hollingshead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0029-6959","authenticated-orcid":false,"given":"Carol","family":"Bentlejewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5711-4912","authenticated-orcid":false,"given":"Erica","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1743-3676","authenticated-orcid":false,"given":"Penelope A.","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7523-3437","authenticated-orcid":false,"given":"Parmjeet","family":"Randhawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7540-5016","authenticated-orcid":false,"given":"Adriana","family":"Zeevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6244-0795","authenticated-orcid":false,"given":"Carmen","family":"Lefaucheur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5500-5074","authenticated-orcid":false,"given":"Diana","family":"Metes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ajt.2024.09.018_bib1","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1111\/j.1600-6143.2009.02813.x","article-title":"Outcome of subclinical\u00a0antibody-mediated rejection in kidney transplant recipients\u00a0with preformed donor-specific antibodies","volume":"9","author":"Loupy","year":"2009","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.ajt.2024.09.018_bib2","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/ajt.15898","article-title":"The Banff 2019 Kidney Meeting Report (I): updates on and clarification of criteria for T cell- and antibody-mediated rejection","volume":"20","author":"Loupy","year":"2020","journal-title":"Am J Transplant."},{"issue":"9863","key":"10.1016\/j.ajt.2024.09.018_bib3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(12)61265-3","article-title":"Antibody-mediated vascular rejection of kidney allografts: a population-based study","volume":"381","author":"Lefaucheur","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ajt.2024.09.018_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10140","article-title":"Proposed definitions of antibody-mediated rejection for use as a clinical trial endpoint in kidney transplantation","volume":"35","author":"Roufosse","year":"2022","journal-title":"Transpl Int"},{"issue":"5","key":"10.1016\/j.ajt.2024.09.018_bib5","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/TP.0000000000003095","article-title":"Recommended treatment for antibody-mediated rejection after kidney transplantation: the 2019 expert consensus from the Transplantion Society Working Group","volume":"104","author":"Schinstock","year":"2020","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.ajt.2024.09.018_bib6","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1681\/ASN.2016070797","article-title":"Antibody-mediated rejection due to preexisting versus de novo donor-specific antibodies in kidney allograft recipients","volume":"28","author":"Aubert","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.ajt.2024.09.018_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1681\/ASN.2014111120","article-title":"IgG donor-specific anti-human HLA antibody subclasses and kidney allograft antibody-mediated injury","volume":"27","author":"Lefaucheur","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ajt.2024.09.018_bib8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3389\/fimmu.2016.00433","article-title":"Antibody subclass repertoire and graft outcome following solid organ transplantation","volume":"7","author":"Valenzuela","year":"2016","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ajt.2024.09.018_bib9","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1681\/ASN.2017050589","article-title":"Complement-activating anti-HLA antibodies in kidney transplantation: allograft gene\u00a0expression profiling and response to treatment","volume":"29","author":"Lefaucheur","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"13","key":"10.1016\/j.ajt.2024.09.018_bib10","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ajt.2024.09.018_bib11","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1111\/ajt.15937","article-title":"Sensitization in transplantation: assessment of risk (STAR) 2019 Working Group meeting report","volume":"20","author":"Tambur","year":"2020","journal-title":"Am J Transplant"},{"issue":"24","key":"10.1016\/j.ajt.2024.09.018_bib12","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1182\/blood-2012-01-380121","article-title":"Properties of mouse and human IgG receptors and their contribution to disease models","volume":"119","author":"Bruhns","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.ajt.2024.09.018_bib13","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1111\/j.1600-6143.2010.03201.x","article-title":"NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection","volume":"10","author":"Hidalgo","year":"2010","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2024.09.018_bib14","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/ajt.15699","article-title":"In situ multiplex immunofluorescence analysis of the inflammatory burden in kidney allograft rejection: a new tool to characterize the alloimmune response","volume":"20","author":"Calvani","year":"2020","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2024.09.018_bib15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.kint.2018.08.027","article-title":"Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation","volume":"95","author":"Yazdani","year":"2019","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.ajt.2024.09.018_bib16","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1172\/JCI119616","article-title":"A\u00a0novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease","volume":"100","author":"Wu","year":"1997","journal-title":"J\u00a0Clin Invest"},{"issue":"16","key":"10.1016\/j.ajt.2024.09.018_bib17","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","article-title":"Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses","volume":"113","author":"Bruhns","year":"2009","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.ajt.2024.09.018_bib18","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1158\/0008-5472.CAN-03-2862","article-title":"Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism\u00a0on the concentration-effect relationship","volume":"64","author":"Dall\u2019Ozzo","year":"2004","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.ajt.2024.09.018_bib19","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1111\/ajt.14710","article-title":"Functional Fc gamma receptor gene polymorphisms and donor-specific antibody-triggered microcirculation inflammation","volume":"18","author":"Arnold","year":"2018","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.ajt.2024.09.018_bib20","first-page":"289","article-title":"Expression and function of Fc gamma RII on human natural killer cells","volume":"13","author":"Metes","year":"1994","journal-title":"Nat Immun"},{"issue":"7","key":"10.1016\/j.ajt.2024.09.018_bib21","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1182\/blood.V91.7.2369","article-title":"Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcgammaRIIC gene","volume":"91","author":"Metes","year":"1998","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ajt.2024.09.018_bib22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00109-001-0294-2","article-title":"Allelic polymorphisms in the FcgammaRIIC gene can influence its function on normal human natural killer cells","volume":"80","author":"Ernst","year":"2002","journal-title":"J Mol Med (Berl)."},{"issue":"6","key":"10.1016\/j.ajt.2024.09.018_bib23","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.ajhg.2012.04.018","article-title":"Evolutionary history of copy-number-variable locus for the low-affinity Fc\u03b3 receptor: mutation rate, autoimmune disease, and the legacy of helminth infection","volume":"90","author":"Machado","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"9","key":"10.1016\/j.ajt.2024.09.018_bib24","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1002\/(SICI)1521-4141(199909)29:09<2842::AID-IMMU2842>3.0.CO;2-5","article-title":"Ligand binding specificities and signal transduction pathways of Fc gamma receptor IIc isoforms: the CD32 isoforms expressed by human NK cells","volume":"29","author":"Metes","year":"1999","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.ajt.2024.09.018_bib25","doi-asserted-by":"crossref","first-page":"E640","DOI":"10.1002\/humu.20997","article-title":"Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B","volume":"30","author":"Breunis","year":"2009","journal-title":"Hum Mutat"},{"issue":"6","key":"10.1016\/j.ajt.2024.09.018_bib27","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.4049\/jimmunol.138.6.1657","article-title":"NK susceptibility varies inversely with target cell class I HLA antigen expression","volume":"138","author":"Storkus","year":"1987","journal-title":"J\u00a0Immunol"},{"issue":"5","key":"10.1016\/j.ajt.2024.09.018_bib28","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"issue":"6594","key":"10.1016\/j.ajt.2024.09.018_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/science.abl5197","article-title":"Cross-tissue immune\u00a0cell analysis reveals tissue-specific features in humans","volume":"376","author":"Dom\u00ednguez Conde","year":"2022","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ajt.2024.09.018_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v025.i01","article-title":"FactoMineR: an R package for multivariate analysis","volume":"25","author":"L\u00ea","year":"2008","journal-title":"J Stat Softw."},{"issue":"3","key":"10.1016\/j.ajt.2024.09.018_bib31","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood.V90.3.1109","article-title":"von dem Borne AE, de Haas M. Fc gammaRIIIa-158V\/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L\/R\/H phenotype","volume":"90","author":"Koene","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ajt.2024.09.018_bib32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fimmu.2019.00185","article-title":"Extensive ethnic variation and linkage disequilibrium at the FCGR2\/3 locus: different genetic associations revealed in Kawasaki disease","volume":"10","author":"Nagelkerke","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajt.2024.09.018_bib33","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3389\/fimmu.2016.00288","article-title":"Antibody-dependent NK cell activation is associated with late kidney allograft dysfunction and the complement-independent alloreactive potential of donor-specific antibodies","volume":"7","author":"Legris","year":"2016","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ajt.2024.09.018_bib34","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1038\/s41467-023-39859-7","article-title":"Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection","volume":"14","author":"Lamarth\u00e9e","year":"2023","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.ajt.2024.09.018_bib35","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/JLB.MR0718-269R","article-title":"Mechanisms of natural killer cell-mediated cellular cytotoxicity","volume":"105","author":"Prager","year":"2019","journal-title":"J\u00a0Leukoc Biol"},{"issue":"1","key":"10.1016\/j.ajt.2024.09.018_bib36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1189\/jlb.70.1.18","article-title":"Unlocking the secrets of cytotoxic granule proteins","volume":"70","author":"Smyth","year":"2001","journal-title":"J\u00a0Leukoc Biol"},{"issue":"8","key":"10.1016\/j.ajt.2024.09.018_bib37","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.4049\/jimmunol.156.8.2693","article-title":"Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis","volume":"156","author":"Eischen","year":"1996","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajt.2024.09.018_bib38","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fimmu.2014.00254","article-title":"Contribution of human Fc\u03b3Rs to disease with evidence from human polymorphisms and transgenic animal studies","volume":"5","author":"Gillis","year":"2014","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.ajt.2024.09.018_bib39","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1080\/19420862.2016.1218586","article-title":"The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc \u03b3 receptor","volume":"8","author":"Subedi","year":"2016","journal-title":"MAbs"},{"issue":"19","key":"10.1016\/j.ajt.2024.09.018_bib40","doi-asserted-by":"crossref","first-page":"13172","DOI":"10.1021\/acs.analchem.0c02342","article-title":"Site-specific glycosylation mapping of Fc gamma receptor IIIb from neutrophils of individual healthy donors","volume":"92","author":"Wojcik","year":"2020","journal-title":"Anal Chem"},{"issue":"1","key":"10.1016\/j.ajt.2024.09.018_bib41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/imr.12365","article-title":"Structural analysis of Fc\/Fc\u03b3R complexes: a blueprint for antibody design","volume":"268","author":"Caaveiro","year":"2015","journal-title":"Immunol Rev"},{"issue":"3","key":"10.1016\/j.ajt.2024.09.018_bib42","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V99.3.754","article-title":"Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene","volume":"99","author":"Cartron","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ajt.2024.09.018_bib43","doi-asserted-by":"crossref","first-page":"7903","DOI":"10.1038\/s41598-021-86943-3","article-title":"The FCGR3A 158 V\/V-genotype is associated with decreased survival of renal allografts with chronic active antibody-mediated rejection","volume":"11","author":"Litjens","year":"2021","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.ajt.2024.09.018_bib44","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1161\/CIRCULATIONAHA.117.030435","article-title":"Genetic and functional profiling of CD16-dependent natural killer activation identifies patients at higher risk of cardiac allograft vasculopathy","volume":"137","author":"Paul","year":"2018","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ajt.2024.09.018_bib45","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ajt.2023.12.005","article-title":"Natural killer cell functional genetics and donor-specific antibody-triggered microvascular inflammation","volume":"24","author":"Diebold","year":"2024","journal-title":"Am J Transplant"},{"issue":"216","key":"10.1016\/j.ajt.2024.09.018_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007097","article-title":"Allelic-dependent expression of an activating Fc receptor on B cells enhances humoral immune responses","volume":"5","author":"Li","year":"2013","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.ajt.2024.09.018_bib47","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1182\/blood-2007-03-079913","article-title":"Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura","volume":"111","author":"Breunis","year":"2008","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.ajt.2024.09.018_bib48","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1097\/TP.0000000000003023","article-title":"Imlifidase inhibits HLA antibody-mediated NK cell activation and antibody-dependent cell-mediated cytotoxicity (ADCC) in vitro","volume":"104","author":"Ge","year":"2020","journal-title":"Transplantation"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613524005732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613524005732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:55:28Z","timestamp":1769907328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613524005732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1600613524005732"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2024.09.018","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FCGR2C Q13 and FCGR3A V176 alleles jointly associate with worse natural killer cell-mediated antibody-dependent cellular cytotoxicity and microvascular inflammation in kidney allograft antibody-mediated rejection","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2024.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}